Houston Registry Core

The Houston Registry Core (HRC) is one of the principal data and biospecimen centres of MAC and is based at McGovern Medical School at UTHealth Houston.

The HRC manages the collection, organization, and secure storage of clinical and genetic data contributed by participating MAC sites worldwide. Its overarching mission is to support collaborative research that improves diagnosis, risk stratification, and management of Heritable Thoracic Aortic Disease (HTAD) and related vascular disorders.

Mission and Function of the Houston Registry Core

The HRC supports data harmonization, quality control, genetic variant classification, and the integration of clinical and genomic information to improve risk stratification, surveillance, treatment planning, and clinical guidelines.

The HRC maintains one of the world’s most comprehensive registries for inherited HTAD. Data received from MAC institutions include:

By compiling high-quality, standardized data from thousands of individuals, the HRC enables analysis that would be impossible at a single institution.

As an international collaboration, MAC relies on consistent data to ensure accuracy and reliability. The HRC ensures:

This ensures that research conclusions are reliable and can be translated into clinical practice.

Genetics is central to understanding HTAD.

The HRC works with expert geneticists to:

This integration allows MAC to identify important differences in risk between genes, helping guide surveillance and treatment.

The Houston Registry Core uses secure research platforms such as REDCap for the storage and management of MAC data.

Its responsibilities include:

This structure supports a transparent, ethical, and compliant research environment.

The HRC enables a broad range of research initiatives, including:

The registry is essential for producing the high-impact publications and guidelines that help physicians care for patients more effectively.

Importance of the Houston Registry Core

For physicians, the HRC provides evidence that shapes surveillance recommendations, informs timing for elective aortic repair, and refines management strategies based on genotype.

Participation from patients around the world is what makes the HRC possible. Their contributions drive discoveries that ultimately lead to safer, more effective approaches to preventing aortic complications.

For patients and families, the HRC represents a commitment to understanding their conditions more deeply, improving early diagnosis, and advancing personalized care rooted in scientific evidence.